BACKGROUND: Meningeal metastasis (MM) is a form of malignant metastasis where tumor cells spread from the primary site to the pia mater, dura mater, arachnoid, subarachnoid space, and other cerebrospinal fluid compartments. Lung cancer is one of the most common malignant tumor types with MM. MM not only signifies that the lung cancer has progressed to an advanced stage but also leads to a range of severe clinical symptoms due to meningeal involvement. Currently, the risk factors associated with the development of MM are not fully elucidated. The aim of this study was to investigate the risk factors for MM in patients with lung adenocarcinoma (LUAD) who underwent non-surgical interventions, in order to identify LUAD patients at high risk for MM. METHODS: This retrospective study analyzed the clinical data of patients diagnosed with LUAD at the First Affiliated Hospital of Zhengzhou University from January 2020 to July 2024. Missing data were imputed using multiple imputation methods, and risk factors were identified through LASSO, univariate, and multivariate Logistic regression analyses. RESULTS: A total of 170 patients with LUAD were included in this study and divided into two groups: 87 patients with MM and 83 patients without MM. Univariate and multivariate Logistic regression analyses revealed that younger age at diagnosis (P=0.004), presence of the epidermal growth factor receptor (EGFR) L858R gene mutation (P=0.008), and concurrent liver metastasis at baseline (P=0.004) were independent risk factors for developing MM in LUAD patients who did not undergo surgical intervention. Conversely, higher baseline globulin levels (P=0.039) and the presence of the anaplastic lymphoma kinase (ALK) gene mutation (P=0.040) were associated with a reduced risk of MM development. CONCLUSIONS Age at diagnosis, EGFR L858R mutation status, ALK gene mutation status, concurrent liver metastasis, globulin levels at baseline were significantly associated with the risk of developing MM in patients with LUAD patients who did not undergo surgical intervention. For patients diagnosed at a younger age, carrying the EGFR L858R mutation, or presenting with baseline liver metastasis, early implementation of tertiary prevention strategies for MM is crucial. Regular monitoring of MM status should be conducted in these high-risk groups.
Humans ; Male ; Adenocarcinoma of Lung/therapy* ; Female ; Middle Aged ; Risk Factors ; Lung Neoplasms/therapy* ; Retrospective Studies ; Aged ; Meningeal Neoplasms/genetics* ; Adult

Objective To investigate the effects of baicalein on the expression of inflammatory factors in bronchial epithelial cell(BEC),and explore the underlying regulatory mechanisms involved.Methods Log-phase 16 HBE cells were categorized into five groups:the normal control group,the toluene diisocyanate(TDI)-stimulated group,and the low-,medium-,and high-dose baica-lein groups.The normal control group was cultured with standard medium,while the TDI-stimulated group was treated with TDI-human serum albumin(TDI-HSA)to establish an asthma-like cell model.Following TDI-HSA stimulation,the low-,medium-,and high-dose baicalein groups were intervened with baicalein at final concentrations of 10,20 and 40μmol/L for48hours.Cell viability was assessed using the CCK-8 assay,and lactate dehydrogenase(LDH)release assays were performed to evaluate the LDH release rate.Flow cytometry was used to determine the rate of pyroptosis.Enzyme-linked immunosorbent assays(ELISA)were conducted to measure the levels of interleukin-1β(IL-1β),interleukin-6(IL-6)and interleukin-18(IL-18)in the culture supernatants.Protein ex-pression levels of NLR family,pyrin domain-containing protein 3(NLRP3),cysteine-dependent aspartate-specific protease 1(caspase-1),Gasdermin D and apoptosis-associated speck-like protein containing a CARD(ASC)were examined via Western blot analysis.Results Compared with the normal control group,the cell viability in the TDI stimulation group decreased(P＜0.05),and the LDH release rate,pyroptosis rate,and the levels of IL-1β,IL-6 and IL-18 in the supernatant all increased(P＜0.05).Com-pared with the TDI-stimulated group,the cell viability in the low-,medium-,and high-dose baicalein groups increased(P＜0.05),while the LDH release rate,pyroptosis rate,and the levels of IL-1β,IL-6 and IL-18 in the supernatant all decreased(P＜0.05),and all in a dose-dependent manner(P＜0.05).Compared with the normal control group,the protein expressions of NLRP3,caspase-1,Gasdermin D and ASC in the TDI-stimulated group were all increased(P＜0.05).Compared with the TDI-stimulated group,the protein expressions of NLRP3,caspase-1,Gasdermin D and ASC in the low-,medium-and high-dose baicalein groups were all decreased(P＜0.05),also in a dose-dependent manner(P＜0.05).Conclusion Baicalein may alleviate TDI-induced the expression of inflammatory factors in BEC by modulating the pyroptosis pathway.Through this mechanism,scutellarin enhances cell viabil-ity and reduces the rate of pyroptosis.

Objective To investigate the effects of baicalein on the expression of inflammatory factors in bronchial epithelial cell(BEC),and explore the underlying regulatory mechanisms involved.Methods Log-phase 16 HBE cells were categorized into five groups:the normal control group,the toluene diisocyanate(TDI)-stimulated group,and the low-,medium-,and high-dose baica-lein groups.The normal control group was cultured with standard medium,while the TDI-stimulated group was treated with TDI-human serum albumin(TDI-HSA)to establish an asthma-like cell model.Following TDI-HSA stimulation,the low-,medium-,and high-dose baicalein groups were intervened with baicalein at final concentrations of 10,20 and 40μmol/L for48hours.Cell viability was assessed using the CCK-8 assay,and lactate dehydrogenase(LDH)release assays were performed to evaluate the LDH release rate.Flow cytometry was used to determine the rate of pyroptosis.Enzyme-linked immunosorbent assays(ELISA)were conducted to measure the levels of interleukin-1β(IL-1β),interleukin-6(IL-6)and interleukin-18(IL-18)in the culture supernatants.Protein ex-pression levels of NLR family,pyrin domain-containing protein 3(NLRP3),cysteine-dependent aspartate-specific protease 1(caspase-1),Gasdermin D and apoptosis-associated speck-like protein containing a CARD(ASC)were examined via Western blot analysis.Results Compared with the normal control group,the cell viability in the TDI stimulation group decreased(P＜0.05),and the LDH release rate,pyroptosis rate,and the levels of IL-1β,IL-6 and IL-18 in the supernatant all increased(P＜0.05).Com-pared with the TDI-stimulated group,the cell viability in the low-,medium-,and high-dose baicalein groups increased(P＜0.05),while the LDH release rate,pyroptosis rate,and the levels of IL-1β,IL-6 and IL-18 in the supernatant all decreased(P＜0.05),and all in a dose-dependent manner(P＜0.05).Compared with the normal control group,the protein expressions of NLRP3,caspase-1,Gasdermin D and ASC in the TDI-stimulated group were all increased(P＜0.05).Compared with the TDI-stimulated group,the protein expressions of NLRP3,caspase-1,Gasdermin D and ASC in the low-,medium-and high-dose baicalein groups were all decreased(P＜0.05),also in a dose-dependent manner(P＜0.05).Conclusion Baicalein may alleviate TDI-induced the expression of inflammatory factors in BEC by modulating the pyroptosis pathway.Through this mechanism,scutellarin enhances cell viabil-ity and reduces the rate of pyroptosis.

ObjectiveTo investigate the application value of liver/spleen CT value （CT_L/S）， controlled attenuation parameter （CAP）， and magnetic resonance imaging-proton density fat fraction （MRI-PDFF） in chronic hepatitis B （CHB） patients with hepatic steatosis. MethodsA retrospective analysis was performed for the clinical data of 213 CHB patients who underwent liver CT， CAP， and MRI-PDFF examinations in Affiliated Hospital of Yan’an University from October 2018 to December 2022. According to MRI-PDFF， the 213 patients were divided into CHB group with 111 patients （MRI-PDFF<5%） and CHB+hepatic steatosis group with 102 patients （MRI-PDFF≥5%）， among whom there were 69 patients with mild hepatic steatosis and 33 patients with moderate to severe hepatic steatosis. The independent-samples t test was used for comparison of normally distributed continuous data between groups， and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups. The Bland-Altman plot was used to evaluate the consistency in MRI-PDFF measurement between two physicians. The Spearman’s correlation coefficient was used to analyze the correlation between CT_L/S and MRI-PDFF and between CAP and MRI-PDFF. The receiver operating characteristic （ROC） curve was plotted and the area under the ROC curve （AUC） was calculated to investigate the value of CT_L/S and CAP in the diagnosis of different degrees of hepatic steatosis， and the DeLong test was used to compare the AUCs of the two radiological examinations. ResultsMRI-PDFF had relatively high repeatability and stability in CHB patients. There is a significant negative correlation between CT_L/S and MRI-PDFF （r=-0.800， P<0.001） and a significant positive correlation between CAP and MRI-PDFF （r=0.692， P<0.001）. Both CT_L/S and CAP had a relatively high accuracy in the diagnosis of hepatic steatosis in CHB patients， with an AUC of 0.951 and 0.902， respectively， and CT_L/S had a better accuracy than CAP （P<0.05）. In the diagnosis of mild and moderate-to-severe hepatic steatosis， CT_L/S had an AUC of 0.921 and 0.895， respectively， and CAP had an AUC of 0.859 and 0.825， respectively， suggesting that CT_L/S had a slightly higher diagnostic efficiency than CAP. ConclusionMRI-PDFF has high repeatability and stability in CHB patients， and CT_L/S and CAP have a high diagnostic value for different degrees of hepatic steatosis in CHB patients.

Objective To monitor the susceptibility of clinical isolates to antimicrobial agents in healthcare facilities in major regions of China in 2023.Methods Clinical isolates collected from 73 hospitals across China were tested for antimicrobial susceptibility using a unified protocol based on disc diffusion method or automated testing systems.Results were interpreted using the 2023 Clinical & Laboratory Standards Institute (CLSI) breakpoints.Results A total of 445199 clinical isolates were collected in 2023,of which 29.0％ were gram-positive and 71.0％ were gram-negative.The prevalence of methicillin-resistant strains in Staphylococcus aureus,Staphylococcus epidermidis and other coagulase-negative Staphylococcus species (excluding Staphylococcus pseudintermedius and Staphylococcus schleiferi) (MRSA,MRSE and MRCNS) was 29.6％,81.9％ and 78.5％,respectively.Methicillin-resistant strains showed significantly higher resistance rates to most antimicrobial agents than methicillin-susceptible strains (MSSA,MSSE and MSCNS).Overall,92.9％ of MRSA strains were susceptible to trimethoprim-sulfamethoxazole and 91.4％ of MRSE strains were susceptible to rifampicin.No vancomycin-resistant strains were found.Enterococcus faecalis had significantly lower resistance rates to most antimicrobial agents tested than Enterococcus faecium.A few vancomycin-resistant strains were identified in both E.faecalis and E.faecium.The prevalence of penicillin-susceptible Streptococcus pneumoniae was 93.1％ in the isolates from children and and 95.9％ in the isolates from adults.The resistance rate to carbapenems was lower than 15.0％ for most Enterobacterales species except for Klebsiella,22.5％ and 23.6％ of which were resistant to imipenem and meropenem,respectively .Most Enterobacterales isolates were highly susceptible to tigecycline,colistin and polymyxin B,with resistance rates ranging from 0.6％ to 10.0％.The resistance rate to imipenem and meropenem was 21.9％ and 17.4％ for Pseudomonas aeruginosa,respectively,and 67.5％ and 68.1％ for Acinetobacter baumannii,respectively.Conclusions Increasing resistance to the commonly used antimicrobial agents is still observed in clinical bacterial isolates.However,the prevalence of important crabapenem-resistant organisms such as crabapenem-resistant K.pneumoniae,P.aeruginosa,and A.baumannii showed a slightly decreasing trend.This finding suggests that strengthening bacterial resistance surveillance and multidisciplinary linkage are important for preventing the occurrence and development of bacterial resistance.

Objective To monitor the susceptibility of clinical isolates to antimicrobial agents in tertiary hospitals in major regions of China in 2022.Methods Clinical isolates from 58 hospitals in China were tested for antimicrobial susceptibility using a unified protocol based on disc diffusion method or automated testing systems.Results were interpreted using the 2022 Clinical &Laboratory Standards Institute(CLSI)breakpoints.Results A total of 318 013 clinical isolates were collected from January 1,2022 to December 31,2022,of which 29.5％were gram-positive and 70.5％were gram-negative.The prevalence of methicillin-resistant strains in Staphylococcus aureus,Staphylococcus epidermidis and other coagulase-negative Staphylococcus species(excluding Staphylococcus pseudintermedius and Staphylococcus schleiferi)was 28.3％,76.7％and 77.9％,respectively.Overall,94.0％of MRSA strains were susceptible to trimethoprim-sulfamethoxazole and 90.8％of MRSE strains were susceptible to rifampicin.No vancomycin-resistant strains were found.Enterococcus faecalis showed significantly lower resistance rates to most antimicrobial agents tested than Enterococcus faecium.A few vancomycin-resistant strains were identified in both E.faecalis and E.faecium.The prevalence of penicillin-susceptible Streptococcus pneumoniae was 94.2％in the isolates from children and 95.7％in the isolates from adults.The resistance rate to carbapenems was lower than 13.1％in most Enterobacterales species except for Klebsiella,21.7％-23.1％of which were resistant to carbapenems.Most Enterobacterales isolates were highly susceptible to tigecycline,colistin and polymyxin B,with resistance rates ranging from 0.1％to 13.3％.The prevalence of meropenem-resistant strains decreased from 23.5％in 2019 to 18.0％in 2022 in Pseudomonas aeruginosa,and decreased from 79.0％in 2019 to 72.5％in 2022 in Acinetobacter baumannii.Conclusions The resistance of clinical isolates to the commonly used antimicrobial agents is still increasing in tertiary hospitals.However,the prevalence of important carbapenem-resistant organisms such as carbapenem-resistant K.pneumoniae,P.aeruginosa,and A.baumannii showed a downward trend in recent years.This finding suggests that the strategy of combining antimicrobial resistance surveillance with multidisciplinary concerted action works well in curbing the spread of resistant bacteria.

In the procurement management of public hospitals, the proposal of procurement demands and the formulation of procurement budgets are completed by different departments, which can easily lead to the generation of ineffective demands. Strengthening procurement demand management has become an important management direction to promote cost reduction and efficiency increase in hospitals. The authors established a procurement demand management mechanism for public hospitals based on the KANO model. The procurement demands of public hospitals were identified according to basic, expected, charismatic, indifference, and reverse types. Then, a demand satisfaction principle that conforms to the hospital resource allocation principle was formulated, and the demand satisfaction process was supervised by establishing a risk sharing mechanism, selecting qualified decision agents, and establishing a process constraint mechanism. A certain hospital has been implementing procurement demand management practices based on this management mechanism since 2022, effectively strengthening the awareness of procurement demand management, improving the efficiency of resource allocation decision-making and the role of demand traction. This can provide reference for the procurement demand management of public hospitals.

Objective To monitor the susceptibility of clinical isolates to antimicrobial agents in healthcare facilities in major regions of China in 2023.Methods Clinical isolates collected from 73 hospitals across China were tested for antimicrobial susceptibility using a unified protocol based on disc diffusion method or automated testing systems.Results were interpreted using the 2023 Clinical & Laboratory Standards Institute (CLSI) breakpoints.Results A total of 445199 clinical isolates were collected in 2023,of which 29.0％ were gram-positive and 71.0％ were gram-negative.The prevalence of methicillin-resistant strains in Staphylococcus aureus,Staphylococcus epidermidis and other coagulase-negative Staphylococcus species (excluding Staphylococcus pseudintermedius and Staphylococcus schleiferi) (MRSA,MRSE and MRCNS) was 29.6％,81.9％ and 78.5％,respectively.Methicillin-resistant strains showed significantly higher resistance rates to most antimicrobial agents than methicillin-susceptible strains (MSSA,MSSE and MSCNS).Overall,92.9％ of MRSA strains were susceptible to trimethoprim-sulfamethoxazole and 91.4％ of MRSE strains were susceptible to rifampicin.No vancomycin-resistant strains were found.Enterococcus faecalis had significantly lower resistance rates to most antimicrobial agents tested than Enterococcus faecium.A few vancomycin-resistant strains were identified in both E.faecalis and E.faecium.The prevalence of penicillin-susceptible Streptococcus pneumoniae was 93.1％ in the isolates from children and and 95.9％ in the isolates from adults.The resistance rate to carbapenems was lower than 15.0％ for most Enterobacterales species except for Klebsiella,22.5％ and 23.6％ of which were resistant to imipenem and meropenem,respectively .Most Enterobacterales isolates were highly susceptible to tigecycline,colistin and polymyxin B,with resistance rates ranging from 0.6％ to 10.0％.The resistance rate to imipenem and meropenem was 21.9％ and 17.4％ for Pseudomonas aeruginosa,respectively,and 67.5％ and 68.1％ for Acinetobacter baumannii,respectively.Conclusions Increasing resistance to the commonly used antimicrobial agents is still observed in clinical bacterial isolates.However,the prevalence of important crabapenem-resistant organisms such as crabapenem-resistant K.pneumoniae,P.aeruginosa,and A.baumannii showed a slightly decreasing trend.This finding suggests that strengthening bacterial resistance surveillance and multidisciplinary linkage are important for preventing the occurrence and development of bacterial resistance.

Purpose: This study aimed to investigate sub-health status (SHS) of people living in China during the Coronavirus disease 2019 (COVID-19) COVID-19 pandemic. COVID-19 is a severe acute respiratory syndrome coronavirus (SARS-CoV) infection-induced acute infectious disease, which is featured by universal susceptibility and strong infectivity, and SHS (a status of low quality health) refers to a status of low-quality health. COVID-19 has gradually developed into a global pandemic, making the public in a high stress situation in physiological, psychological and social states in the short term. Methods: From March 6 to 11, 2020, a large-scale cross-sectional survey was conducted by convenient sampling, and SHS assessment scale was used in the questionnaire. The ordinal logistic regression analysis was used to identify the factors affecting SHS. Results: In this study, 17,078 questionnaires were delivered with 16,820 effective questionnaires collected, and 10,715 subjects (63.7%) were found with SHS, with moderate SHS primarily. Physiological sub-scale scored the highest, followed by psychological and social sub-scales. Ordinal logistic regression analysis indicated that man, only-child, workers and farmers were risk factors of SHS. Protective factors of SHS included living in rural areas and townships, laid-off retirees and education degree. Conclusion It shows many people in China place in a poor health status during COVID-19 pandemic. It is necessary that relevant departments pay more attention to people with poor health such as men, only-child, urban people, workers and farmers, and groups with high education degree during and after pandemic stabilization.

Objective To investigate the effect of Dexmedetomidine on postoperative impairment of cognitive function in elderly patients undergoing thoracoscopic surgery under wireless analgesia.Methods Eighty elderly patients undergoing thoracoscopic surgery in our hospital from May 2017 to April 2018 were randomly divided into the S group(n=40)receiving Sufentanil under wireless analgesia,and the DS group receiving Dexmedetomidine as add-on to the therapy for S group.The mini-mental state examination(MMSE) score,postoperative pain degree,and serum levels of interleukin(IL)-1,IL-6 and tumor necrosis factor(TNF)-α,as well as adverse reactions were compared between the two groups,preoperatively and postoperatively.Results MMSE score was higher in the DS group than in the S group at 1 and 3 days after operation[(26.85±1.20)vs.(26.33±1.33),(26.65± 1.16)vs.(26.00± 1.29),t =1.795 and 2.370,P =0.038 and 0.010].Pain visual analog scale(VAS)score was lower in the DS group than in the S group at 6 and 12 hours after operation[(4.32±0.64)vs.(4.65±0.77),(4.01±0.45)vs.(4.23±0.59),t=2.138 and 1.875,P=0.018 and 0.032,respectively].At 1 and 3 days after operation,IL-1,IL-6 and TNF-α levels were higher in SD group than in S group (P ＜ 0.05).But,at 5 and 7 days after operation,there was no significant difference in the expression levels of IL-1,IL-6 and TNF between the two groups (P ＞0.05).The incidence of nausea was lower in DS group than in S group(2.5％ vs.15.0％,x2 =3.914,P=0.048),while the incidence of bradycardia was higher in the DS group than in the S group(17.5％ vs.2.5 ％,x2 =5.000,P =0.025).Conclusions Dexmedetomidine not only effectively alleviates the postoperative pain and improves cognitive function in elderly patients undergoing thoracoscopic management under wireless analgesia,but also reduces postoperative inflammatory levels.